Core Insights - Rocket Doctor AI Inc. has appointed Dr. Anikia Nelson as Director of Product and Bilal Malik as Director of Engineering to enhance its digital health platform and support growth in North America [1][8] Group 1: Leadership Appointments - Dr. Anikia Nelson brings over a decade of experience in clinical care and product strategy, previously serving as Physician Strategy Manager at Doximity and Senior Director at Clarify Health Solutions [2][3] - Bilal Malik has more than ten years of experience in engineering, focusing on AI-enabled, cloud-native platforms, and previously led AI strategy at Pricedex Software [4][5] Group 2: Strategic Goals - The appointments aim to strengthen product direction, platform innovation, and scalability, enhancing Rocket Doctor's ability to deliver high-quality healthcare solutions [1][7] - The company is focused on expanding its reach in underserved markets and enhancing its AI capabilities to improve healthcare accessibility [7][13] Group 3: Company Overview - Rocket Doctor AI Inc. provides AI-powered solutions designed to enhance the patient journey and has supported over 300 MDs in managing more than 700,000 patient visits [11][12] - The company aims to reduce administrative burdens and improve physician-patient interactions, particularly in rural and underserved communities [13]

Core Insights - Rocket Doctor AI Inc. has expanded its in-network access by partnering with a major California-based health plan, providing services to an additional 330,000 Medicare Advantage members and over 1.7 million commercially insured members [1][8] Group 1: Strategic Expansion - The agreement enhances Rocket Doctor's strategic growth in California, integrating its digital health platform with leading payer networks [2] - This expansion aims to improve member access to timely, high-quality care and supports efficient healthcare delivery across diverse patient populations [2][5] Group 2: Service Offerings - Physicians in Rocket Doctor's multi-specialty practice will offer a range of services through the digital health platform, including primary care consultations, chronic condition management, virtual urgent care, and preventive health services [4][8] - The platform connects patients with board-certified physicians and utilizes integrated care management tools to address both immediate and ongoing healthcare needs [4] Group 3: Market Position - The latest agreement reinforces Rocket Doctor's position as a trusted partner to payers and providers, advancing its mission to enhance access, affordability, and equity in healthcare [5] - The company has previously announced similar expansions, indicating ongoing momentum in both government-sponsored and commercial insurance markets [3][8]

Core Viewpoint - Rocket Doctor AI Inc. has successfully exercised a significant number of common share purchase warrants, generating substantial gross proceeds, which reflects investor confidence in the company's strategy and growth plans [2][3]. Group 1: Warrant Exercise Details - A total of 3,242,030 warrants were exercised between July 5, 2024, and March 13, 2026, at a price of $0.60, resulting in gross proceeds of approximately CAD$1,945,218 [2]. - An additional 172,866 warrants were exercised from a separate issuance related to debt settlement, generating approximately CAD$103,720, bringing total gross proceeds from warrant exercises to approximately CAD$2,048,938 [2][7]. - In the three months leading up to March 13, 2026, 2,054,224 warrants were exercised, resulting in gross proceeds of approximately CAD$1,232,535 [3][7]. Group 2: Company Strategy and Vision - The CEO of Rocket Doctor AI emphasized that the exercise of warrants indicates ongoing confidence in the company's long-term vision and strategy, particularly in expanding its AI-powered healthcare platform [3]. - The proceeds from the warrant exercises will be utilized for working capital and general corporate purposes as the company continues its growth plans in the U.S. market [3][7]. - Rocket Doctor AI aims to enhance healthcare accessibility through its proprietary technology, including the Global Library of Medicine (GLM), which supports physicians in delivering high-quality care [4][6]. Group 3: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to improve patient access and streamline the healthcare process [4][5]. - The company has empowered over 300 MDs to manage more than 700,000 patient visits, showcasing the effectiveness of its technology in enhancing healthcare delivery [5]. - The focus is on reaching underserved communities in Canada and supporting patients on Medicaid and Medicare in the U.S., aiming to create a more equitable healthcare system [6].

Core Insights - Rocket Doctor AI Inc. has expanded its in-network coverage by partnering with a major New York insurer, allowing approximately 20,000 additional Medicare Advantage and Dual-Eligible Medicare Special Needs Plan members to access its services starting April 1, 2026 [1][4] - This agreement is part of Rocket Doctor's strategic efforts to enhance its digital health platform's integration within leading payer networks, thereby improving access to high-quality care for Medicare beneficiaries [2][5] - The company's total in-network coverage now exceeds 15 million lives across major U.S. markets, with New York being a significant growth area [5][8] Expansion and Market Strategy - The recent agreement builds on a previous announcement from March 3, 2026, which expanded access for an additional approximately 2.4 million members across various product lines in New York [3][8] - Rocket Doctor's CEO emphasized the importance of new payer partnerships in enhancing timely, technology-enabled care for Medicare members, particularly in high-need populations [4][5] - The digital health platform will provide a range of services, including primary care consultations, chronic condition support, preventive health services, and coordinated follow-up care [4][8] Technology and Service Delivery - Rocket Doctor AI Inc. utilizes AI-powered solutions to improve healthcare accessibility throughout the patient journey, supported by its Global Library of Medicine, a clinically validated decision support system [6][7] - The platform has enabled over 300 physicians to manage more than 700,000 patient visits, enhancing efficiency and patient access to care [7][8] - The technology aims to reduce administrative burdens and improve the quality of physician-patient interactions, particularly in underserved communities [8]

Core Insights - Rocket Doctor AI Inc. has expanded its network by partnering with a major insurer in New York State, providing in-network access to over 2.4 million members [1][2] - This agreement enhances Rocket Doctor's presence in New York, a significant healthcare market, and aligns with the company's strategy to integrate its platform within established payer networks [2][6] - The total in-network reach of Rocket Doctor now exceeds 15 million covered lives across key U.S. markets, reinforcing its rapid growth and impact on healthcare accessibility [5][8] Company Expansion - The new agreement allows Rocket Doctor to participate in a variety of care products, including Medicaid Managed Care, Medicare Advantage, and individual plans, thereby broadening its service offerings [3][4] - The partnership aims to improve access to timely, high-quality care for underserved populations, particularly in government-sponsored programs [4][8] - This expansion follows a previous announcement where Rocket Doctor secured contracts providing access to 3.8 million members under two major insurers [5] Technology and Services - Rocket Doctor's digital health platform and marketplace are designed to empower physicians and improve patient access to care, having facilitated over 700,000 patient visits [9][10] - The company's technology reduces administrative burdens, allowing for more meaningful interactions between physicians and patients [10] - Rocket Doctor is committed to reaching underserved communities and enhancing healthcare equity through its AI-powered solutions [10]

Core Insights - Rocket Doctor AI Inc. has engaged Danayi Capital Corp. for digital marketing services for a two-month term starting February 9, 2026, with an upfront payment of USD$125,000 [1] - The company has granted a total of 33,353 stock options at an exercise price of $0.77 per share and 205,065 restricted share units to consultants, both valid for three years and subject to a one-year vesting period [3] - Rocket Doctor AI focuses on providing AI-powered healthcare solutions, aiming to improve access to quality healthcare through its proprietary technology, including the Global Library of Medicine [4][6] Company Overview - Rocket Doctor AI Inc. offers physician-built, AI-driven solutions designed to enhance the patient journey and healthcare accessibility [4] - The company has supported over 300 MDs in delivering care to more than 700,000 patient visits, enabling doctors to manage their own virtual or hybrid practices [5] - The technology aims to reduce administrative burdens, allowing for more meaningful interactions between physicians and patients, particularly in underserved communities [6]

Core Insights - Rocket Doctor AI Inc. has expanded its network by partnering with a major insurer for commercial employer-sponsored health plans in California, enhancing access for eligible members to board-certified physicians [1][4][8] - This agreement increases Rocket Doctor's in-network reach to over 13 million covered lives across key U.S. markets, primarily California and New York, reflecting the company's rapid growth and impact on healthcare accessibility [3][8] - The partnership aligns with the company's strategy to embed its physician-led platform within established payer networks, improving access to high-quality care while reducing friction for patients [2][5] Company Expansion - The new agreement includes approximately 175,000 members in California, further solidifying Rocket Doctor's presence in one of the largest healthcare markets in the U.S. [8] - The company aims to enhance its payer mix, which is expected to support sustained revenue growth across its U.S. operations [5][8] - The partnership allows Rocket Doctor to provide convenient, clinician-led care to working individuals and families, meeting the quality and accessibility standards of a leading national insurer [4] Technology and Services - Rocket Doctor AI delivers AI-powered solutions designed to make high-quality healthcare accessible throughout the patient journey, supported by the Global Library of Medicine (GLM) [6][7] - The platform has empowered over 300 MDs to provide care for more than 700,000 patient visits, improving efficiency and expanding patient access to care [7] - The technology reduces administrative burdens, allowing for more meaningful physician-patient interactions and supporting underserved communities [8][9]

Core Viewpoint - Rocket Doctor AI Inc. has successfully closed a non-brokered private placement, raising approximately C$5,200,000 through the issuance of 7,428,571 units at C$0.70 per unit, which will support the company's growth strategy, particularly in the U.S. market [1][2]. Group 1: Offering Details - The offering consisted of units, each comprising one common share and one warrant, with warrants exercisable at C$0.85 until January 22, 2027 [2]. - The offering was completed under the listed issuer financing exemption, meaning the securities are not subject to a hold period under Canadian securities laws [3]. - The company paid a cash commission of C$198,800 to finders and issued 284,000 non-transferrable warrants, also exercisable at C$0.85 until January 22, 2027 [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated towards digital marketing, customer acquisition, operating and administrative expenses, research and development, and general working capital [5]. Group 3: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions aimed at improving access to quality healthcare throughout the patient journey, leveraging a clinically validated decision support system [7]. - The company has empowered over 300 MDs to manage more than 700,000 patient visits, enhancing efficiency and expanding patient access to care [8]. - The technology aims to reduce administrative burdens and improve physician-patient interactions, particularly targeting underserved communities in Canada and supporting patients on Medicaid and Medicare in the U.S. [9][10].

Core Viewpoint - Rocket Doctor AI Inc. has increased its non-brokered private placement offering to a maximum of $4.5 million due to high demand, with each unit priced at $0.70 [1] Group 1: Offering Details - The offering has been upsized from its initial announcement on January 9, 2025, and the amended offering document is available on the company's profile and website [2] - All other terms of the offering remain unchanged despite the increase in the maximum gross proceeds [1] Group 2: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to enhance accessibility throughout the patient journey, featuring the Global Library of Medicine (GLM) as a key component [4] - The company has empowered over 300 physicians to manage more than 700,000 patient visits, enabling doctors to launch and manage virtual or hybrid practices [5] - The technology aims to reduce administrative burdens, improve care consistency, and enhance physician-patient interactions, particularly targeting underserved communities in Canada and patients on Medicaid and Medicare in the U.S. [6]

Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to enhance accessibility throughout the patient journey, utilizing a proprietary technology known as the Global Library of Medicine (GLM) [2][4] - The company has developed a digital health platform that empowers over 300 physicians to manage more than 700,000 patient visits, facilitating the launch of virtual or hybrid practices [3] Recent Developments - Rocket Doctor AI has granted a total of 75,000 stock options at an exercise price of $0.74 per share, along with 212,148 restricted share units to consultants, both valid for three years and subject to a one-year vesting period [1] Technology and Impact - The technology aims to reduce administrative burdens and improve the consistency of care, allowing for more meaningful interactions between physicians and patients [4] - The company is focused on serving underserved, rural, and remote communities in Canada, as well as supporting patients on Medicaid and Medicare in the United States, thereby promoting equitable healthcare access [4]